tirzepatide phase 3 study results The SURMOUNT-MAINTAIN 3b trial is testing if adults with obesity can maintain weight loss by continuing or reducing (vs placebo) after achieving on the highest dose. #Tirzepatide https://t.co/FHyoDXDEYv A Phase 1 Multiple Dose

While there is no clear timeline for when the drug will be listed, once it is, the price will be dramatically slashed for eligible patients

Its value shows up when it is the right tool for the right patient, a stalled injury or a stubborn gut issue, delivered as a verified, correctly dosed, supervised protocol

So, we shouldnt become obsessed with the micro changes we might see on the scales each day, as theyre unlikely to tell us whether weve lost body fat

If youre feeling sluggish or finding it tough to stay active, B12 injections for weight loss could help boost your energy levels

[18] Keeping a symptom diary noting the timing, location, and severity of skin reactions can provide valuable information for the clinical team